We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
+4.32%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$846M
AUM Growth
+$36.6M
Cap. Flow
+$4.36M
Cap. Flow %
0.52%
Top 10 Hldgs %
27.6%
Holding
188
New
6
Increased
51
Reduced
84
Closed
4

Top Buys

Rank Stock Value
1
WY icon
Weyerhaeuser
WY
+$4.32M
2
MTB icon
M&T Bank
MTB
+$4.19M
3
JCI icon
Johnson Controls International
JCI
+$4.14M
4
GILD icon
Gilead Sciences
GILD
+$3.61M
5
ALB icon
Albemarle
ALB
+$3.34M

Top Sells

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$4.22M
2
EMR icon
Emerson Electric
EMR
+$3.1M
3
ADSK icon
Autodesk
ADSK
+$2.11M
4
AMAT icon
Applied Materials
AMAT
+$1.62M
5
AMGN icon
Amgen
AMGN
+$1.36M

Sector Composition

Rank Sector Weight
1 Technology 22.45%
2 Healthcare 18.78%
3 Industrials 11.12%
4 Consumer Staples 10.98%
5 Financials 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
151
DELISTED
Celgene Corp
CELG
$342K 0.04%
2,630
DUK icon
152
Duke Energy
DUK
$101B
$338K 0.04%
4,039
-233
-5% -$19.6K
CPB icon
153
Campbell Soup
CPB
$6.8B
$332K 0.04%
6,367
GSK icon
154
GSK
GSK
$108B
$332K 0.04%
6,154
-180
-3% -$9.6K
EOG icon
155
EOG Resources
EOG
$74.4B
$322K 0.04%
3,555
-76
-2% -$7K
KDP icon
156
Keurig Dr Pepper
KDP
$42.3B
$316K 0.04%
3,469
WFM
157
DELISTED
Whole Foods Market Inc
WFM
$316K 0.04%
7,493
-500
-6% -$18.2K
BIIB icon
158
Biogen
BIIB
$30.4B
$311K 0.04%
1,147
MHK icon
159
Mohawk Industries
MHK
$7.14B
$302K 0.04%
1,251
+250
+25% +$59K
EPD icon
160
Enterprise Products Partners
EPD
$83.6B
$284K 0.03%
10,496
AME icon
161
Ametek
AME
$55.3B
$282K 0.03%
4,650
-48
-1% -$2.83K
NBIX icon
162
Neurocrine Biosciences
NBIX
$18.4B
$282K 0.03%
6,130
+810
+15% +$39.3K
K
163
DELISTED
Kellanova
K
$279K 0.03%
4,280
-12
-0.3% -$807
TGT icon
164
Target
TGT
$65.5B
$273K 0.03%
5,219
-67
-1% -$3.66K
LQD icon
165
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.5B
$272K 0.03%
2,255
APC
166
DELISTED
Anadarko Petroleum
APC
$268K 0.03%
5,911
NVO
167
Novo Nordisk
NVO
$225B
$265K 0.03%
12,334
ORLY icon
168
O'Reilly Automotive
ORLY
$75.6B
$261K 0.03%
17,865
+5,415
+43% +$88.4K
WRK
169
DELISTED
WestRock Company
WRK
$261K 0.03%
4,601
TXN icon
170
Texas Instruments
TXN
$253B
$259K 0.03%
3,373
-3,093
-48% -$248K
IVV icon
171
iShares Core S&P 500 ETF
IVV
$871B
$249K 0.03%
1,025
GPC icon
172
Genuine Parts
GPC
$17.9B
$244K 0.03%
2,632
-660
-20% -$60.7K
TIF
173
DELISTED
Tiffany & Co.
TIF
$243K 0.03%
2,586
BKNG icon
174
Booking.com
BKNG
$154B
$238K 0.03%
+3,175
New +$233K
DD icon
175
DuPont de Nemours
DD
$19B
$231K 0.03%
1,443
-228
-14% -$36.2K

Similar funds

Grandfield & Dodd's Q2 2017 Portfolio in Review

As of Q2 2017, Grandfield & Dodd held 188 positions worth $846M, up 4.5% from $810M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Grandfield & Dodd's Q2 2017 filing shows 6 new, 51 increased, 84 reduced and 4 closed positions. Its largest new stake was Weyerhaeuser: 128,274 shares worth $4.3M. The largest sale was Enbridge, an estimated $4.22M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Grandfield & Dodd's largest Q2 2017 buy was Weyerhaeuser: 128,274 shares worth $4.3M.
  • Grandfield & Dodd added most to M&T Bank in Q2 2017, an estimated $4.19M increase.
  • Grandfield & Dodd's biggest Q2 2017 reduction was Enbridge, cutting an estimated $4.22M.
  • Grandfield & Dodd fully exited Syngenta Ag in Q2 2017, selling an estimated $280K.
  • Grandfield & Dodd's ten largest holdings make up 28% of its $846M portfolio in Q2 2017.
  • Grandfield & Dodd opened 6 new positions and closed 4 in Q2 2017.
  • Grandfield & Dodd's portfolio value rose 4.5% quarter-over-quarter to $846M.

Based on Grandfield & Dodd's 13F filing for Q2 2017, filed 27 Jul 2017.